ReviewACS biomaterials science & engineering2025
Microfluidic Systems to Mimic the Blood-Brain Barrier: from Market to Engineering Challenges and Perspectives.
Review in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- CRISPR-Enabled functional genomics in hPSCs-derived neural models for autism spectrum disorder.Metabolic brain disease · 2026Review
- Organ-on-a-Chip and Microfluidic Plant Cell Culture Systems: The Next Frontier for Controlled Secondary Metabolite Production and Real-Time Metabolomic Monitoring.Plants (Basel, Switzerland) · 2026Review
- Article
- A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing.Materials today. Bio · 2026Article
- Modeling blood-brain barrier-glioblastoma interactions: implications for chemoresistance and therapeutic targeting.Fluids and barriers of the CNS · 2026Review
- Construction, evaluation, and applications of renal barrier-on-a-chip system.Bioactive materials · 2026Review
- Plant-derived nanocarriers & nanostructures for barrier-defined translation: a comprehensive review of mechanisms, targets, and translation.Journal of nanobiotechnology · 2026Review
- Vascularised Brain Organoids: Engineering Strategies and Neurobiological Applications.Cell proliferation · 2026Review
- Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors.Advanced drug delivery reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studying and understanding complex biological systems is a challenge that requires technologies that go beyond traditional cell culture methods. Among the new technologies that have been developed in recent times, blood-brain barrier-on-a-chip (BBB-on-a-chip) models are becoming popular. Due to their ability to integrate fluid flow, which is absent in traditional static models, it has been possible to create a cellular microenvironment that mimics blood vessels and blood flow. In addition, the possibility of coculturing different cell types in multicellular models allows the observation of their interactions and increases interest in these systems. With different possibilities in terms of prototyping techniques (e.g., laminate manufacturing, molding, and 3D impression), chip designs (e.g., planar and cylindrical configurations), and materials (e.g., thermoplastics, elastomers, and hydrogels), the number of publications in the BBB research field has significantly increased in the last five years. In parallel, the emergence and consolidation of several companies have made the commercialization and application of these chips possible, mainly in the pharmaceutical area, which is not yet integrated into the drug development pipeline. In this context, the present review describes the intersection between technique, market, and applications that mimic the BBB. We showed organ-on-a-chip (OoC) market growth and the collaborative research between the main OoC supplier companies and industrial collaborators. Also, we present an overview of the primary fabrication methods used in constructing the OoC systems and their application in developing the BBB models. In addition, we discussed the BBB-on-a-chip designs developed in the last five years, including their engineering aspects (such as materials, dimensions, and configuration), characterization, and challenges in mimicking the BBB.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.